Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
February 16, 2022
Webinar
Strafford Publications
As part of the Strafford Publications’ webinar series, Finnegan partners Mark Feldstein and David Weingarten will review the FDA's recent guidance on biologics and biosimilars and how it impacts patent strategy. For more information, or to register, please see Strafford’s website.
Related Practices
Related Industries
Related Professionals
- Mark J. Feldstein, Ph.D.
- Partner
- Washington, D.C.
- +1 202 408 4092
- M. David Weingarten, Ph.D.
- Partner
- Atlanta, GA
- +1 404 653 6457
